Darzalex 400mg (Daratumumab Vials) 400mg/20ml

Darzalex 400mg (daratumumab) is an injectable medication used in cancer therapy. Store between 2-8°C and protect from light. This Swiss-made vial supports targeted treatment protocols. Suitable for patients requiring monoclonal antibody therapy.

Strength

400mg/20ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Janssen - Cilag AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daratumumab is used to treat certain types of blood cancers, including multiple myeloma. It works by targeting specific proteins on cancer cells to help slow or stop their growth. This medication is often prescribed for patients who have not responded to other therapies. It may be used alone or combined with other treatments.

Side Effects

Patients may experience infusion-related reactions, which can include chills, nausea, or fatigue. Some individuals report changes in blood cell counts or infections during treatment. Regular monitoring helps manage these effects. Hydration and rest are commonly recommended during therapy.

Precautions & Warnings

This medication should be handled by healthcare professionals in a clinical setting. Keep vials refrigerated and protect from light until use. Avoid exposure to extreme temperatures. Patients should report any signs of infection or unusual symptoms immediately.

Avoid Interactions

Daratumumab may interact with other medications that affect the immune system, such as immunosuppressants or corticosteroids. Combining with live vaccines is generally not recommended. Always inform healthcare providers about all medications being taken. Alcohol and certain supplements may also interact.

References

Frequently Asked Questions

Daratumumab is used to treat multiple myeloma and other blood cancers by targeting cancer cells.

It is given as an intravenous infusion under medical supervision in a healthcare setting.

Infusion reactions like chills, nausea, and fatigue are commonly reported during treatment.

No, it must be refrigerated between 2-8°C and protected from light.

It may interact with immunosuppressants, live vaccines, and certain supplements.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.